Jane Gilbert

676 total citations · 1 hit paper
9 papers, 501 citations indexed

About

Jane Gilbert is a scholar working on Rheumatology, Physiology and Pharmacology. According to data from OpenAlex, Jane Gilbert has authored 9 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rheumatology, 3 papers in Physiology and 2 papers in Pharmacology. Recurrent topics in Jane Gilbert's work include Asthma and respiratory diseases (3 papers), Peripheral Neuropathies and Disorders (2 papers) and Inflammatory mediators and NSAID effects (2 papers). Jane Gilbert is often cited by papers focused on Asthma and respiratory diseases (3 papers), Peripheral Neuropathies and Disorders (2 papers) and Inflammatory mediators and NSAID effects (2 papers). Jane Gilbert collaborates with scholars based in United Kingdom, United States and Netherlands. Jane Gilbert's co-authors include Ana R. Sousa, Richard P. Marshall, Aoife C. Maxwell, Valerie Lund, Shuaib Nasser, Claus Bachert, Philippe Gevaert, Wytske J. Fokkens, Harsha H. Kariyawasam and Daren Austin and has published in prestigious journals such as PLoS ONE, Journal of Allergy and Clinical Immunology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Jane Gilbert

9 papers receiving 486 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial

2017 352 citations Claus Bachert, Ana R. Sousa et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane Gilbert United Kingdom	6	322	261	251	137	99	9	501
Kit Wong United States	6	441 1.4×	472 1.8×	388 1.5×	163 1.2×	126 1.3×	9	716
Aiko I. Klingler United States	8	373 1.2×	388 1.5×	446 1.8×	186 1.4×	60 0.6×	14	629
Juby A. Jacob‐Nara United States	14	548 1.7×	327 1.3×	240 1.0×	191 1.4×	246 2.5×	112	801
Claus Bachert Germany	6	194 0.6×	149 0.6×	120 0.5×	105 0.8×	80 0.8×	14	349
Stuart Harlin United States	4	189 0.6×	164 0.6×	164 0.7×	115 0.8×	138 1.4×	6	353
S.M. Reinartz Netherlands	10	205 0.6×	191 0.7×	82 0.3×	82 0.6×	72 0.7×	19	348
Kęstutis Malakauskas Lithuania	14	311 1.0×	80 0.3×	13 0.1×	89 0.6×	172 1.7×	52	460
H. Luckhaupt Germany	8	60 0.2×	62 0.2×	146 0.6×	145 1.1×	64 0.6×	32	309
VJ Lund Australia	4	220 0.7×	243 0.9×	52 0.2×	100 0.7×	93 0.9×	5	360
Gero Quante Germany	9	37 0.1×	60 0.2×	191 0.8×	246 1.8×	32 0.3×	21	393

Countries citing papers authored by Jane Gilbert

Since Specialization

Citations

This map shows the geographic impact of Jane Gilbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Gilbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Gilbert more than expected).

Fields of papers citing papers by Jane Gilbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Gilbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Gilbert. The network helps show where Jane Gilbert may publish in the future.

Co-authorship network of co-authors of Jane Gilbert

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Gilbert. A scholar is included among the top collaborators of Jane Gilbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Gilbert. Jane Gilbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Begg, Malcolm, J. Hamblin, Robert C. Wilson, et al.. (2019). Translation of Inhaled Drug Optimization Strategies into Clinical Pharmacokinetics and Pharmacodynamics Using GSK2292767A, a Novel Inhaled Phosphoinositide 3-Kinase δ Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 369(3). 443–453. 14 indexed citations

2.

Bachert, Claus, Ana R. Sousa, Valerie Lund, et al.. (2017). Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial. Journal of Allergy and Clinical Immunology. 140(4). 1024–1031.e14. 352 indexed citations breakdown →

3.

Struemper, Herbert, Jane Gilbert, Matthew E. Barton, et al.. (2015). Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects. Clinical Pharmacology in Drug Development. 5(3). 208–215. 26 indexed citations

4.

Dhariwal, Jaideep, Jeremy Kitson, Grant C. Nicholson, et al.. (2015). Nasal Lipopolysaccharide Challenge and Cytokine Measurement Reflects Innate Mucosal Immune Responsiveness. PLoS ONE. 10(9). e0135363–e0135363. 15 indexed citations

5.

Struemper, Herbert, Jane Gilbert, James Groark, et al.. (2015). THU0403 A Randomised, Open-Label Study to Evaluate the Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector. Annals of the Rheumatic Diseases. 74. 342–343. 1 indexed citations

6.

Wilson, Robert C., Anthony Cahn, Jonathan Green, et al.. (2014). Safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single (SD) and repeat (RD) inhaled doses of a novel phosphoinositide 3-kinase δ inhibitor (PI3Kδ), GSK2269557, administered to healthy smokers. European Respiratory Journal. 44(Suppl 58). 3411–3411. 4 indexed citations

7.

Neighbour, Helen, L.‐P. Boulet, Catherine Lemière, et al.. (2013). Safety and efficacy of an oral CCR3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo‐controlled clinical trial. Clinical & Experimental Allergy. 44(4). 508–516. 68 indexed citations

8.

Grond, Stefan, Brigitte Kuperwasser, Mila Etropolski, et al.. (2009). 342 DOSE STABILITY OF TAPENTADOL EXTENDED RELEASE AND OXYCODONE CONTROLLED RELEASE IN A ONE-YEAR, RANDOMIZED, OPEN-LABEL, PHASE 3 SAFETY TRIAL IN PATIENTS WITH CHRONIC LOW BACK OR OSTEOARTHRITIS PAIN. Osteoarthritis and Cartilage. 17. S181–S182. 1 indexed citations

9.

Næsh, Ole, et al.. (2005). A randomized, placebo-controlled study of rofecoxib with paracetamol in early post-tonsillectomy pain in adults. European Journal of Anaesthesiology. 22(10). 768–773. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact